Study of the combination gemcitabine and trastuzumab in the treatment of HER2+metastatic breast cancer

被引：0
|
作者：
Menjon-Beltran, S. [1 ]
Olivencia-Dueso, R. [1 ]
Gonzalez-Jimenez, E. [1 ]
Titos, M. J. [1 ]
机构：
[1] Hosp Univ Virgen Nieves, Unidad Ginecol Oncol, Granada, Spain
来源：
BREAST CANCER RESEARCH | 2007年 / 9卷 / 01期
关键词：
Gemcitabine; Trastuzumab; Clinical Benefit; Stable Disease; Metastatic Breast Cancer;
D O I：
10.1186/bcr1717
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Relapsed/Refractory HER2+Metastatic Breast Cancer
    Brufsky, Adam M.
    Gadi, V. K.
    Hurvitz, Sara A.
    Iyengar, Neil M.
    ONCOLOGY-NEW YORK, 2021, 35 (04): : 215 - 219
  • [32] Phase III study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)
    Dieras, V. C.
    Martin Jimenez, M.
    O'Sullivan, C. C. M.
    Sohn, J.
    Tryfonidis, K.
    Santarpia, L.
    Yang, S.
    Hamilton, E. P.
    ANNALS OF ONCOLOGY, 2022, 33 : S222 - S222
  • [33] A feasibility study of combination therapy with trastuzumab (T), cyclophosphamide (CY), and an allogeneic GM-CSF-secreting breast tumor vaccine for the treatment of HER2+metastatic breast cancer.
    Emens, L. A.
    Gupta, R.
    Petrik, S.
    Laiko, M.
    Leatherman, J. M.
    Levi, J.
    Asquith, J. M.
    Daphtary, M. M.
    Garrett-Mayer, E.
    Kobrin, B. J.
    Davidson, N. E.
    Dauses, T.
    Atay-Rosenthal, S.
    Ye, X.
    Wolff, A. C.
    Stearns, V.
    Jaffee, E. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)
    Mueller, V
    Hamilton, E.
    Tsurutani, J.
    Curigliano, G.
    Martin, M.
    O'Sullivan, C.
    Sohn, J.
    Tryfonidis, K.
    Santarpia, L.
    Yang, S.
    Dieras, V
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 173 - 173
  • [35] Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)
    Hamilton, Erika
    Tsurutani, Junji
    Sohn, Joohyuk
    Curigliano, Giuseppe
    O'Sullivan, Ciara C.
    Martin, Miguel
    Tryfonidis, Konstantinos
    Santarpia, Libero
    Yang, Shan
    Dieras, Veronique
    CANCER RESEARCH, 2023, 83 (08)
  • [36] Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)
    Hamilton, Erika
    Tsurutani, Junji
    Curigliano, Giuseppe
    Martin, Miguel
    O'Sullivan, Ciara C.
    Sohn, Joo Hyuk
    Tryfonidis, Konstantinos
    Santarpia, Libero
    Yang, Shan
    Dieras, Veronique
    CANCER RESEARCH, 2023, 83 (05)
  • [37] Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress).
    Hamilton, Erika P.
    Maria O'Sullivan, Ciara Catherine
    Martin, Miguel
    Sohn, Joohyuk
    Tryfonidis, Konstantinos
    Santarpia, Libero
    Yang, Shan
    Dieras, Veronique C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)
    Kiver, Verena
    Hamilton, Erika
    Tsurutani, Junji
    Curigliano, Giuseppe
    Martin, Miguel
    O'sullivan, Ciara
    Sohn, Joo Hyuk
    Tryfonidis, Konstantinos
    Santarpia, Libero
    Yang, Shan
    Dieras, Veronique
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 39 - 39
  • [39] Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+Metastatic Breast Cancer (HER2CLIMB-05, Trial in Progress)
    Hamilton, Erika
    Tsurutani, Junji
    Curigliano, Giuseppe
    Martin, Miguel
    O'Sullivan, Ciara
    Sohn, Joo Hyuk
    Tryfonidis, Konstantinos
    Santarpia, Libero
    Yang, Shan
    Dieras, Veronique
    CANCER RESEARCH, 2024, 84 (09)
  • [40] Evolving perspectives on the treatment of HR+/HER2+metastatic breast cancer
    Pegram, Mark
    Pietras, Richard
    Dang, Chau T.
    Murthy, Rashmi
    Bachelot, Thomas
    Janni, Wolfgang
    Sharma, Priyanka
    Hamilton, Erika
    Saura, Cristina
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345